Skip to Main Content

Access to Essential Medicines at Primary Level Facilities: China Case Study

2015

This case study describes China’s essential medicines program and “zero mark-up” policy for drugs and intravenous injections. These initiatives, introduced in 2009, sought to reduce the inappropriate use of drugs and ensure access to safe, affordable medications. The case explores the impact of these policies on service quality, resource usage, and performance-based compensation of primary healthcare institutions.

This case is part of the World Health Organization’s collection of health financing policy resources, which includes case studies, reports, policy briefs, and other resources organized by topic. The resource portal also includes information on the WHO’s policy framework for health financing along with relevant World Health Assembly and regional resolutions and strategies, courses and trainings, diagnostics and guidance, and rich data resources including databases and country profiles.

Source:

Wenhui C. Wen C. Improving Health System Efficiency: China: The Zero Mark-up Policy for Essential Medicines at Primary Level Facilities. World Health Organization 2015. https://apps.who.int/iris/handle/10665/188623.